These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

253 related items for PubMed ID: 30840191

  • 1. Relative and Absolute Expression Analysis of MicroRNAs Associated with Luminal A Breast Cancer- A Comparison.
    Arabkari V, Clancy E, Dwyer RM, Kerin MJ, Kalinina O, Holian E, Newell J, Smith TJ.
    Pathol Oncol Res; 2020 Apr; 26(2):833-844. PubMed ID: 30840191
    [Abstract] [Full Text] [Related]

  • 2. Identification and validation of oncologic miRNA biomarkers for luminal A-like breast cancer.
    McDermott AM, Miller N, Wall D, Martyn LM, Ball G, Sweeney KJ, Kerin MJ.
    PLoS One; 2014 Apr; 9(1):e87032. PubMed ID: 24498016
    [Abstract] [Full Text] [Related]

  • 3. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection.
    Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW, Fasching PA.
    PLoS One; 2012 Apr; 7(1):e29770. PubMed ID: 22242178
    [Abstract] [Full Text] [Related]

  • 4. A circulating miRNA signature as a diagnostic biomarker for non-invasive early detection of breast cancer.
    Zhang L, Xu Y, Jin X, Wang Z, Wu Y, Zhao D, Chen G, Li D, Wang X, Cao H, Xie Y, Liang Z.
    Breast Cancer Res Treat; 2015 Nov; 154(2):423-34. PubMed ID: 26476723
    [Abstract] [Full Text] [Related]

  • 5. Cross Platform Standardisation of an Experimental Pipeline for Use in the Identification of Dysregulated Human Circulating MiRNAs.
    Kelly H, Downing T, Tuite NL, Smith TJ, Kerin MJ, Dwyer RM, Clancy E, Barry T, Reddington K.
    PLoS One; 2015 Nov; 10(9):e0137389. PubMed ID: 26355751
    [Abstract] [Full Text] [Related]

  • 6. Circulating microRNAs miR-331 and miR-195 differentiate local luminal a from metastatic breast cancer.
    McAnena P, Tanriverdi K, Curran C, Gilligan K, Freedman JE, Brown JAL, Kerin MJ.
    BMC Cancer; 2019 May 10; 19(1):436. PubMed ID: 31077182
    [Abstract] [Full Text] [Related]

  • 7. Serum circulating microRNA profiling for identification of potential breast cancer biomarkers.
    Mar-Aguilar F, Mendoza-Ramírez JA, Malagón-Santiago I, Espino-Silva PK, Santuario-Facio SK, Ruiz-Flores P, Rodríguez-Padilla C, Reséndez-Pérez D.
    Dis Markers; 2013 May 10; 34(3):163-9. PubMed ID: 23334650
    [Abstract] [Full Text] [Related]

  • 8. Plasma microRNAs as potential new biomarkers for early detection of early gastric cancer.
    Zhu XL, Ren LF, Wang HP, Bai ZT, Zhang L, Meng WB, Zhu KX, Ding FH, Miao L, Yan J, Wang YP, Liu YQ, Zhou WC, Li X.
    World J Gastroenterol; 2019 Apr 07; 25(13):1580-1591. PubMed ID: 30983818
    [Abstract] [Full Text] [Related]

  • 9. Small non-coding RNA profiling in breast cancer: plasma U6 snRNA, miR-451a and miR-548b-5p as novel diagnostic and prognostic biomarkers.
    Záveský L, Jandáková E, Weinberger V, Minář L, Hanzíková V, Dušková D, Faridová A, Turyna R, Slanař O, Hořínek A, Kohoutová M.
    Mol Biol Rep; 2022 Mar 07; 49(3):1955-1971. PubMed ID: 34993725
    [Abstract] [Full Text] [Related]

  • 10. Diagnostic and prognostic implications of microRNA profiling in prostate carcinoma.
    Schaefer A, Jung M, Mollenkopf HJ, Wagner I, Stephan C, Jentzmik F, Miller K, Lein M, Kristiansen G, Jung K.
    Int J Cancer; 2010 Mar 01; 126(5):1166-76. PubMed ID: 19676045
    [Abstract] [Full Text] [Related]

  • 11. Robust expression of tumor suppressor miRNA's let-7 and miR-195 detected in plasma of Saudi female breast cancer patients.
    Qattan A, Intabli H, Alkhayal W, Eltabache C, Tweigieri T, Amer SB.
    BMC Cancer; 2017 Nov 28; 17(1):799. PubMed ID: 29183284
    [Abstract] [Full Text] [Related]

  • 12. Identification of microRNA biomarkers in the blood of breast cancer patients based on microRNA profiling.
    Zhang K, Wang YW, Wang YY, Song Y, Zhu J, Si PC, Ma R.
    Gene; 2017 Jul 01; 619():10-20. PubMed ID: 28359916
    [Abstract] [Full Text] [Related]

  • 13. Absolute Quantification of Plasma MicroRNA Levels in Cynomolgus Monkeys, Using Quantitative Real-time Reverse Transcription PCR.
    Iguchi T, Niino N, Tamai S, Sakurai K, Mori K.
    J Vis Exp; 2018 Feb 12; (132):. PubMed ID: 29553521
    [Abstract] [Full Text] [Related]

  • 14. A nine-miRNA signature as a potential diagnostic marker for breast carcinoma: An integrated study of 1,110 cases.
    Xiong DD, Lv J, Wei KL, Feng ZB, Chen JT, Liu KC, Chen G, Luo DZ.
    Oncol Rep; 2017 Jun 12; 37(6):3297-3304. PubMed ID: 28440475
    [Abstract] [Full Text] [Related]

  • 15. Diagnostic and prognostic significance of miRNA signatures in tissues and plasma of endometrioid endometrial carcinoma patients.
    Torres A, Torres K, Pesci A, Ceccaroni M, Paszkowski T, Cassandrini P, Zamboni G, Maciejewski R.
    Int J Cancer; 2013 Apr 01; 132(7):1633-45. PubMed ID: 22987275
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of miRNA-9 and miRNA-34a as potential biomarkers for diagnosis of breast cancer in Iranian women.
    Orangi E, Motovali-Bashi M.
    Gene; 2019 Mar 01; 687():272-279. PubMed ID: 30468908
    [Abstract] [Full Text] [Related]

  • 17. MicroRNA Expression Profiling to Identify and Validate Reference Genes for the Relative Quantification of microRNA in Rectal Cancer.
    Eriksen AH, Andersen RF, Pallisgaard N, Sørensen FB, Jakobsen A, Hansen TF.
    PLoS One; 2016 Mar 01; 11(3):e0150593. PubMed ID: 26937645
    [Abstract] [Full Text] [Related]

  • 18. Identification of miRNAs Enriched in Extracellular Vesicles Derived from Serum Samples of Breast Cancer Patients.
    Ozawa PMM, Vieira E, Lemos DS, Souza ILM, Zanata SM, Pankievicz VC, Tuleski TR, Souza EM, Wowk PF, Urban CA, Kuroda F, Lima RS, Almeida RC, Gradia DF, Cavalli IJ, Cavalli LR, Malheiros D, Ribeiro EMSF.
    Biomolecules; 2020 Jan 16; 10(1):. PubMed ID: 31963351
    [Abstract] [Full Text] [Related]

  • 19. Value of miR-31 and miR-150-3p as diagnostic and prognostic biomarkers for breast cancer.
    Erturk E, Ari F, Onur OE, Mustafa Gokgoz S, Tolunay S.
    Mol Biol Rep; 2024 Oct 01; 51(1):1030. PubMed ID: 39352561
    [Abstract] [Full Text] [Related]

  • 20. Circulating microRNAs in plasma as early detection markers for breast cancer.
    Cuk K, Zucknick M, Heil J, Madhavan D, Schott S, Turchinovich A, Arlt D, Rath M, Sohn C, Benner A, Junkermann H, Schneeweiss A, Burwinkel B.
    Int J Cancer; 2013 Apr 01; 132(7):1602-12. PubMed ID: 22927033
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.